Tag:
bicifadine
Latest Headlines
Latest Headlines
Tiny XTL cuts costs, jobs
New York-based XTL Biopharmaceuticals won't be able to recover from the failure of its diabetic neuropathic pain drug bicifadine . XLT announced today that it is laying off nine employees, or 75
XTL shares clobbered on lead drug trial failure
Shares of New York-based XTL Biopharmaceuticals were almost completely wiped out overnight after the developer announced that a mid-stage trial of its lead therapy failed to hit its primary endpoint.
